Adagio shares soar on antibody potential against new COVID variant omicron By: TalkMarkets November 29, 2021 at 13:05 PM EST Stifel analyst Stephen Willey believes vaccines alone are unlikely to sufficiently address the COVID-19 pandemic. Read More >> Related Stocks: Adagio Therapeutics Inc Astrazeneca Plc ADR Eli Lilly Merck & Co Moderna Inc Novavax Inc Pfizer Regeneron Pharmaceuticals Vir Biotechnology Inc